Patents by Inventor Victoria A. O'Neill

Victoria A. O'Neill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMEDIATE RELEASE DOSAGE FORMS THAT DETER ABUSE BY ORAL INGESTION OF MULTIPLE DOSAGE UNITS
    Publication number: 20170157052
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: December 7, 2016
    Publication date: June 8, 2017
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20170143637
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: February 2, 2017
    Publication date: May 25, 2017
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20160317457
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: July 14, 2016
    Publication date: November 3, 2016
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Dermatological compositions and methods
    Patent number: 9456970
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: October 4, 2016
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Gloria A. Rood, Kenneth L. Evenstad, Victoria A. O'Neill
  • ABUSE-DETERRENT DOSAGE FORMS
    Publication number: 20160256392
    Abstract: Described are oral dosage forms that contain abuse-deterrent features and that contain a matrix with gelling polymer and disintegrant, with particular examples including immediate release dosage forms that contain a drug that is commonly susceptible to abuse.
    Type: Application
    Filed: July 17, 2014
    Publication date: September 8, 2016
    Inventors: Dinesh K. HASWANI, Derek V MOE, Victoria A. O'NEILL, Manuel A. VEGA ZEPEDA
  • IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
    Publication number: 20160250203
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: October 29, 2014
    Publication date: September 1, 2016
    Inventors: Dinesh K. HASWANI, Derek V MOE, Victoria A. O'NEILL, Manuel A. VEGA ZEPEDA
  • DERMATOLOGICAL COMPOSITIONS AND METHODS
    Publication number: 20160000672
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Application
    Filed: September 11, 2015
    Publication date: January 7, 2016
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: GLORIA A. ROOD, KENNETH L. EVENSTAD, VICTORIA A. O'NEILL
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20150118300
    Abstract: Described are oral dosage forms that contain abuse-deterrent features and that contain core-shell polymers that include an active pharmaceutical ingredient, with particular examples including immediate release dosage forms that contain a drug that is commonly susceptible to abuse.
    Type: Application
    Filed: July 17, 2014
    Publication date: April 30, 2015
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20150118301
    Abstract: Described are oral dosage forms that contain abuse-deterrent features and that contain core-shell polymers that include an active pharmaceutical ingredient, with particular examples including immediate release dosage forms that contain a drug that is commonly susceptible to abuse.
    Type: Application
    Filed: September 4, 2014
    Publication date: April 30, 2015
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20150118295
    Abstract: Described are oral dosage forms that contain abuse-deterrent features and that contain core-shell polymers that include an active pharmaceutical ingredient, with particular examples including immediate release dosage forms that contain a drug that is commonly susceptible to abuse.
    Type: Application
    Filed: September 12, 2014
    Publication date: April 30, 2015
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20150118302
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: October 29, 2014
    Publication date: April 30, 2015
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20150118303
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: November 12, 2014
    Publication date: April 30, 2015
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • DERMATOLOGICAL COMPOSITIONS AND METHODS
    Publication number: 20110288172
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Application
    Filed: August 5, 2011
    Publication date: November 24, 2011
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Gloria A. ROOD, Kenneth L. EVENSTAD, Victoria A. O'NEILL
  • Dermatological compositions and methods
    Patent number: 8013017
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Grant
    Filed: June 5, 2009
    Date of Patent: September 6, 2011
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Gloria A. Rood, Kenneth L. Evenstad, Victoria A. O'Neill
  • DERMATOLOGICAL COMPOSITIONS AND METHODS
    Publication number: 20090247632
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Application
    Filed: June 5, 2009
    Publication date: October 1, 2009
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Gloria A. Rood, Kenneth L. Evenstad, Victoria A. O'Neill, Thomas R. Gorham
  • Dermatological compositions and methods
    Publication number: 20030017181
    Abstract: Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid.
    Type: Application
    Filed: May 31, 2002
    Publication date: January 23, 2003
    Inventors: Gloria A. Rood, Kenneth L. Evenstad, Victoria A. O'Neill, Thomas R. Gorham
  • Rectally-administered, epileptic-seizure-inhibiting composition
    Patent number: 5462740
    Abstract: This invention provides a rectally administered composition for inhibiting epileptic seizure and to its methods of use. The composition contains, in a suitable solvent, an anti-epileptic agent for inhibiting epileptic seizure, a buffer for maintaining pH, and a thickener for imparting a viscosity to the composition effective for rectal administration by injection to a patient in epileptic seizure.
    Type: Grant
    Filed: September 17, 1993
    Date of Patent: October 31, 1995
    Assignee: Athena Neurosciences, Inc.
    Inventors: Kenneth L. Evenstad, Victoria A. O'Neill, Thomas R. Gorham
  • Method of using niacin to control nocturnal cholesterol synthesis
    Patent number: 5268181
    Abstract: The invention provides a therapeutic method to treat hyperlipidemia by administering to a human patient a single daily dose of a prolonged release dosage form of niacin, so that nocturnal cholesterol synthesis is effectively suppressed.
    Type: Grant
    Filed: June 29, 1992
    Date of Patent: December 7, 1993
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Victoria A. O'Neill, Kenneth L. Evenstad
  • Controlled release tablet containing water soluble medicament
    Patent number: 5126145
    Abstract: A sustained or controlled release tablet is disclosed. The tablet comprises a water soluble medicament, a hydroxypropyl methylcellulose having sustaining action, a pharmaceutical binding agent, and a hydrophobic component.
    Type: Grant
    Filed: June 11, 1990
    Date of Patent: June 30, 1992
    Inventors: Kenneth L. Evenstad, Kuldip R. Malhotra, Victoria A. O'Neill